FLNA

FILANA THERAPEUTICS, INC.

Insider activity for last month from 08/30 to 09/30. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingSep 30, 2026Most recent Form 4
Total buying$78.1k1 buys
Total selling$00 sells
Net open-market+$78.1k1 insiders
Open-market mix
Buy vs sell distribution by transaction count
1 transactions
1 buys100%·0%0 sells

Insider activity report

Monthly purchases, sales and code-A awards
Buys Sells Awards / grants (A)
530-3-5transactionsAugSep 2026 buys: 1 transactions · $78.1k1Sep

Code A includes awards, grants and other acquisitions; these are not open-market buys.

Distinct insiders active

Reporting-owner CIKs by month · peak Sep 2026 (1)
Aug 2026Sep 2026
1distinct insiders in 2 months
Top insiders
By absolute net value across the selected period
1 insiders
  • BR
    Barry RichardPRES, CEO · rank 1 · 1 buys · 0 sells · 0 awards (A)
    +$78.2klast 09/30/2026
Recent filing activity
Most recent 1 transactions · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy$78.1k
Largest sale-
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
1transactionstxns
  • P · Open-market buys · dominant1 · 100%

Activity by reported role

A joint filing can contribute to multiple roles
2transactionstxns
  • Chief executive officer · dominant1 · 50%
  • PRES1 · 50%

Reported Holdings After

Separated by insider, security, and ownership type

Barry RichardCommon Stock · Indirect · By Trust
1.0M1.0MSep 28, 2026Sep 28, 2026
1,031,151Sep 28, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
1 active days
Aug 30 → Sep 30
LessMore

Filing-only signals

Deterministic matches in the selected period

FLNA transaction history

Filters apply within this company and selected period by default
Reset

Latest insider transactions

Form 4 filings from last month. Click any column to sort; click it again to flip the order.

Newest company filings

FILANA THERAPEUTICS, INC. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at FILANA THERAPEUTICS, INC.?

Barry Richard.

When was the latest reported open-market purchase?

Barry Richard reported a buy on Sep 28, 2026 valued at $78.1k. Read the SEC filing.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

Net open-market buying in the selected period was $78,196.44. This describes filed transactions, not a bullish rating.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.